195 related articles for article (PubMed ID: 11222565)
1. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice.
Sangaré L; Morisset R; Gaboury L; Ravaoarinoro M
J Antimicrob Chemother; 2001 Mar; 47(3):323-31. PubMed ID: 11222565
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cationic liposome-encapsulated doxycycline in mice challenged with genital infection by Chlamydia trachomatis.
Selliah S; Ravaoarinoro M
Chemotherapy; 2004 Apr; 50(1):17-21. PubMed ID: 15084800
[TBL] [Abstract][Full Text] [Related]
3. In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline.
Sangare L; Morisset R; Ravaoarinoro M
J Med Microbiol; 1999 Jul; 48(7):689-693. PubMed ID: 10403420
[TBL] [Abstract][Full Text] [Related]
4. [In vitro inhibition of Chlamydia trachomatis growth by liposome-encapsulated cyclines].
Sangaré L; Morisset R; Ravaoarinoro M
Pathol Biol (Paris); 2001 Feb; 49(1):53-6. PubMed ID: 11265224
[TBL] [Abstract][Full Text] [Related]
5. Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.
Patton DL; Teng A; Randall A; Liang X; Felgner PL; de la Maza LM
J Proteomics; 2014 Aug; 108():99-109. PubMed ID: 24862987
[TBL] [Abstract][Full Text] [Related]
6. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
[TBL] [Abstract][Full Text] [Related]
9. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
10. Experimental infection of the marmoset genital tract with Chlamydia trachomatis.
Johnson AP; Hetherington CM; Osborn MF; Thomas BJ; Taylor-Robinson D
Br J Exp Pathol; 1980 Jun; 61(3):291-5. PubMed ID: 7426384
[TBL] [Abstract][Full Text] [Related]
11. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.
Su H; Messer R; Whitmire W; Hughes S; Caldwell HD
Infect Immun; 2000 Jan; 68(1):192-6. PubMed ID: 10603387
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis: impact on human reproduction.
Paavonen J; Eggert-Kruse W
Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
[TBL] [Abstract][Full Text] [Related]
13. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis.
Johansson M; Ward M; Lycke N
Immunology; 1997 Dec; 92(4):422-8. PubMed ID: 9497482
[TBL] [Abstract][Full Text] [Related]
14. Effects of doxycycline and antiinflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques.
Patton DL; Sweeney YC; Bohannon NJ; Clark AM; Hughes JP; Cappuccio A; Campbell LA; Stamm WE
J Infect Dis; 1997 Mar; 175(3):648-54. PubMed ID: 9041337
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin.
Beale AS; Upshon PA
Antimicrob Agents Chemother; 1994 Sep; 38(9):1937-43. PubMed ID: 7811001
[TBL] [Abstract][Full Text] [Related]
17. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
Wang J; Chen L; Chen F; Zhang X; Zhang Y; Baseman J; Perdue S; Yeh IT; Shain R; Holland M; Bailey R; Mabey D; Yu P; Zhong G
Vaccine; 2009 May; 27(22):2967-80. PubMed ID: 19428908
[TBL] [Abstract][Full Text] [Related]
18. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.
Darville T; Andrews CW; Laffoon KK; Shymasani W; Kishen LR; Rank RG
Infect Immun; 1997 Aug; 65(8):3065-73. PubMed ID: 9234755
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
Pal S; Peterson EM; de la Maza LM
Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
